Cornerstone Advisors (Washington)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-1,763
| Closed | -$88K | – | 1065 |
|
|
2019
Q2 | $88K | Buy |
1,763
+414
| +31% | +$20.7K | 0.01% | 277 |
|
|
2019
Q1 | $70K | Buy |
1,349
+773
| +134% | +$40.1K | 0.01% | 285 |
|
|
2018
Q4 | $28K | Buy |
576
+17
| +3% | +$826 | 0.01% | 435 |
|
|
2018
Q3 | $28K | Buy |
559
+162
| +41% | +$8.11K | 0.02% | 463 |
|
|
2018
Q2 | $20K | Buy |
397
+205
| +107% | +$10.3K | 0.01% | 505 |
|
|
2018
Q1 | $9K | Buy |
+192
| New | +$9K | 0.01% | 606 |
|
|
2017
Q4 | – | Sell |
-126
| Closed | -$6K | – | 919 |
|
|
2017
Q3 | $6K | Sell |
126
-110
| -47% | -$5.24K | ﹤0.01% | 668 |
|
|
2017
Q2 | $13K | Buy |
236
+159
| +206% | +$8.76K | 0.01% | 547 |
|
|
2017
Q1 | $4K | Hold |
77
| – | – | ﹤0.01% | 715 |
|
|
2016
Q4 | $4K | Sell |
77
-40
| -34% | -$2.08K | ﹤0.01% | 729 |
|
|
2016
Q3 | $6K | Hold |
117
| – | – | 0.01% | 657 |
|
|
2016
Q2 | $6K | Hold |
117
| – | – | 0.01% | 523 |
|
|
2016
Q1 | $6K | Sell |
117
-177
| -60% | -$9.08K | 0.01% | 528 |
|
|
2015
Q4 | $15K | Buy |
294
+280
| +2,000% | +$14.3K | 0.02% | 366 |
|
|
2015
Q3 | $1K | Sell |
14
-86
| -86% | -$6.14K | ﹤0.01% | 806 |
|
|
2015
Q2 | $5K | Hold |
100
| – | – | ﹤0.01% | 407 |
|
|
2015
Q1 | $6K | Buy |
100
+14
| +16% | +$840 | ﹤0.01% | 412 |
|
|
2014
Q4 | $5K | Buy |
+86
| New | +$5K | ﹤0.01% | 390 |
|
|
2014
Q2 | – | Sell |
-250
| Closed | -$17K | – | 671 |
|
|
2014
Q1 | $17K | Sell |
250
-246
| -50% | -$16.7K | 0.02% | 147 |
|
|
2013
Q4 | $33K | Hold |
496
| – | – | 0.05% | 81 |
|
|
2013
Q3 | $31K | Sell |
496
-54
| -10% | -$3.38K | 0.05% | 80 |
|
|
2013
Q2 | $34K | Buy |
+550
| New | +$34K | 0.08% | 36 |
|